Meropenem Bradex

Meropenem, the active ingredient in Meropenem Bradex, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It provides broad‑spectrum bactericidal activity against serious Gram‑negative and Gram‑positive infections in hospitalized patients requiring parenteral therapy.

GNH USA supplies Meropenem Bradex as a licensed, GDP‑compliant international pharmaceutical supplier, delivering the product to hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. Originating from the European Union, the product meets EU pharmacopeial specifications.

Meropenem Bradex is a carbapenem antibiotic indicated for serious bacterial infections affecting various organ systems.

- Complicated intra‑abdominal infections: achieves bacterial eradication in severe abdominal infections. - Complicated urinary tract infections: clears resistant uropathogens causing pyelonephritis and cystitis. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitic pathogens. - Hospital‑acquired pneumonia: provides coverage for multidrug‑resistant respiratory bacteria. - Sepsis: rapidly reduces bacterial load in systemic infections.

Adverse reactions may occur with any intravenous antibiotic and should be monitored during therapy.

Common Side Effects: - Nausea - Diarrhea - Rash or pruritus - Headache - Elevated liver enzymes - Injection‑site phlebitis

Serious or Rare Side Effects: - Anaphylactic or severe allergic reactions - Seizures, especially in patients with renal impairment - Clostridioides difficile‑associated colitis - Severe neutropenia or leukopenia - Acute renal failure - Hepatic failure or severe transaminase elevation

Use of Meropenem Bradex requires careful assessment of patient‑specific factors and monitoring.

- Renal function: adjust dose in patients with impaired clearance. - Seizure risk: monitor individuals with a history of CNS disorders. - Allergy: avoid in patients with known carbapenem hypersensitivity. - Pregnancy: prescribe only when benefits outweigh potential risks. - Antimicrobial stewardship: limit use to confirmed bacterial infections. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem Bradex can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Valproic acid: may reduce serum valproate concentrations. - Probenecid: can increase meropenem plasma levels, raising toxicity risk. - Renally toxic drugs (e.g., aminoglycosides): concurrent use may exacerbate nephrotoxicity.

Moderate Interactions (Monitor Closely): - Loop diuretics: monitor renal function and electrolytes. - Anticoagulants (e.g., warfarin): observe coagulation parameters for potential changes.